These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25349197)

  • 1. Murine Double Minute-2 Prevents p53-Overactivation-Related Cell Death (Podoptosis) of Podocytes.
    Thomasova D; Bruns HA; Kretschmer V; Ebrahim M; Romoli S; Liapis H; Kotb AM; Endlich N; Anders HJ
    J Am Soc Nephrol; 2015 Jul; 26(7):1513-23. PubMed ID: 25349197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte loss involves MDM2-driven mitotic catastrophe.
    Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
    J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.
    Tang H; Lei CT; Ye C; Gao P; Wan C; Chen S; He FF; Wang YM; Su H; Zhang C
    J Cell Mol Med; 2017 Dec; 21(12):3435-3444. PubMed ID: 28643424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 prevents spontaneous tubular epithelial cell death and acute kidney injury.
    Thomasova D; Ebrahim M; Fleckinger K; Li M; Molnar J; Popper B; Liapis H; Kotb AM; Siegerist F; Endlich N; Anders HJ
    Cell Death Dis; 2016 Nov; 7(11):e2482. PubMed ID: 27882940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
    Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
    J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 beyond cancer: podoptosis, development, inflammation, and tissue regeneration.
    Ebrahim M; Mulay SR; Anders HJ; Thomasova D
    Histol Histopathol; 2015 Nov; 30(11):1271-82. PubMed ID: 26062755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.
    El Machhour F; Keuylian Z; Kavvadas P; Dussaule JC; Chatziantoniou C
    J Am Soc Nephrol; 2015 Jul; 26(7):1561-75. PubMed ID: 25421557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress.
    Fang L; Li X; Luo Y; He W; Dai C; Yang J
    Exp Cell Res; 2014 Apr; 322(2):290-301. PubMed ID: 24424244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Human FSGS-Causing
    Hall G; Lane BM; Khan K; Pediaditakis I; Xiao J; Wu G; Wang L; Kovalik ME; Chryst-Stangl M; Davis EE; Spurney RF; Gbadegesin RA
    J Am Soc Nephrol; 2018 Aug; 29(8):2110-2122. PubMed ID: 30002222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How many ways can a podocyte die?
    Tharaux PL; Huber TB
    Semin Nephrol; 2012 Jul; 32(4):394-404. PubMed ID: 22958494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).
    D'Agati VD
    Kidney Int; 2008 Feb; 73(4):399-406. PubMed ID: 17989648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice.
    Mulay SR; Thomasova D; Ryu M; Anders HJ
    Kidney Int; 2012 Jun; 81(12):1199-211. PubMed ID: 22297670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic suppression of prostatic cancer cells by coexpression of both murine double minute 2 small interfering RNA and wild-type p53 gene in vitro and in vivo.
    Ji K; Wang B; Shao YT; Zhang L; Liu YN; Shao C; Li XJ; Li X; Hu JD; Zhao XJ; Xu DQ; Li Y; Cai L
    J Pharmacol Exp Ther; 2011 Jul; 338(1):173-83. PubMed ID: 21444629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP40 deubiquitinates HINT1 and stabilizes p53 in podocyte damage.
    Takahashi S; Fukuhara D; Kimura T; Fukutomi T; Tanaka E; Mikami N; Hada I; Takematsu H; Nishibori Y; Akimoto Y; Kiyonari H; Abe T; Huber O; Yan K
    Biochem Biophys Res Commun; 2022 Jul; 614():198-206. PubMed ID: 35605301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish.
    Chua JS; Liew HP; Guo L; Lane DP
    Oncogene; 2015 Nov; 34(48):5933-41. PubMed ID: 25746004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome.
    Park SJ; Kim Y; Yang SM; Henderson MJ; Yang W; Lindahl M; Urano F; Chen YM
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14154-14163. PubMed ID: 31235574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.
    Michaud JL; Chaisson KM; Parks RJ; Kennedy CR
    Kidney Int; 2006 Sep; 70(6):1054-61. PubMed ID: 16837921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis.
    Tanoue A; Katayama K; Ito Y; Joh K; Toda M; Yasuma T; D'Alessandro-Gabazza CN; Kawachi H; Yan K; Ito M; Gabazza EC; Tryggvason K; Dohi K
    Sci Rep; 2021 Oct; 11(1):20556. PubMed ID: 34654837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.
    Hartleben B; Gödel M; Meyer-Schwesinger C; Liu S; Ulrich T; Köbler S; Wiech T; Grahammer F; Arnold SJ; Lindenmeyer MT; Cohen CD; Pavenstädt H; Kerjaschki D; Mizushima N; Shaw AS; Walz G; Huber TB
    J Clin Invest; 2010 Apr; 120(4):1084-96. PubMed ID: 20200449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis.
    Akilesh S; Suleiman H; Yu H; Stander MC; Lavin P; Gbadegesin R; Antignac C; Pollak M; Kopp JB; Winn MP; Shaw AS
    J Clin Invest; 2011 Oct; 121(10):4127-37. PubMed ID: 21911940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.